Results 151 to 160 of about 98,224 (178)

Docetaxel

Reactions Weekly, 2000
openaire   +2 more sources

Antitumour Activity of Docetaxel Following Treatment With the CYP17A1 Inhibitor Abiraterone: Clinical Evidence for Cross-Resistance?

Annals of Oncology, 2012
Gerhardt Attard, Shahneen K Sandhu, E Sheridan   +2 more
exaly  

Docetaxel

Reactions Weekly, 2023
openaire   +1 more source

A Phase II Study of Single-Agent Docetaxel in Patients With Metastatic Esophageal Cancer

Annals of Oncology, 2004
Narikazu Boku, Keishô Chin, Tomoko Ohtsu   +2 more
exaly  

Docetaxel

Reactions Weekly, 2014
openaire   +1 more source

The Impact of Docetaxel-Related Toxicities on Health-Related Quality of Life in Patients With Metastatic Cancer (QoliTax)

Annals of Oncology, 2015
S-E Al-Batran, R -D Hofheinz, C Pauligk
exaly  

Randomized Phase II Study of Docetaxel Plus Estramustine and Single-Agent Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer

Annals of Oncology, 2007
F Priou, P Kerbrat, D Genet
exaly  

Randomized Phase III Study of 3-Weekly Versus Weekly Docetaxel in Pretreated Advanced Non-Small-Cell Lung Cancer: A Spanish Lung Cancer Group Trial

Annals of Oncology, 2006
Alfredo Carrato, Mariano Provencio, Carlos Camps   +2 more
exaly  

Phase III Trial of Docetaxel Plus Gemcitabine Versus Docetaxel in Second-Line Treatment for Non-Small-Cell Lung Cancer: Results of a Japan Clinical Oncology Group Trial (JCOG0104)

Annals of Oncology, 2009
S Kudoh, S Negoro, Y Nishiwaki
exaly  

Randomized Phase III Trial Comparing Docetaxel Plus Epirubicin Versus Docetaxel Plus Capecitabine as First-Line Treatment in Women With Advanced Breast Cancer

Annals of Oncology, 2010
N Malamos, Ch Kouroussis, N Kentepozidis
exaly